Author

J. Skoda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 4 Approach:experimental assay· 4 Organism:human· 4 Assay:proteomics· 3 Research Focus:drug response / drug discovery· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Assay:imaging· 1

Frequent Co-Authors

J. Neradil· 2 shared M. D. Hogarty· 2 shared A. Kubistova· 1 shared A. Vu· 1 shared C. P. Reynolds· 1 shared D. Lanbe· 1 shared D. M. Booth· 1 shared D. R. Richardson· 1 shared

Activity by Year

2021-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

J. Neradil

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Dysregulation of the p53 pathway provides a therapeutic target in aggressive pediatric sarcomas with stem-like traits

L. Curylova, I. Staniczkova Zambo, J. Neradil, M. Kyr, N. Jurackova, S. Pavlova, K. Polaskova, P. Mudry, J. Sterba, R. Veselska, J. Skoda

This study shows that restoring p53 activity can target aggressive pediatric sarcomas with stem-like traits by inducing apoptosis in cancer cells while sparing healthy cells.

bioRxiv · Jan 17, 2024Cancer Biology

Melanotransferrin Functions as a Pro-Oncogenic WNT Agonist: A Yin-Yang Relationship in Melanoma with the WNT Antagonist and Metastasis Suppressor, NDRG1

D. R. Richardson, J. Paluncic, M. Gholam Azad, D. Lanbe, J. Skoda, K. Park, S. Chiang, D.-H. Bae, R. Scolyer, R. Afroz, G. Babu, J. Wilmott, K. Loh, P. Jansson, M. Dharmasivam, , Z. Kovacevic

This study identifies MTf as a pro-oncogenic WNT agonist that forms a bidirectional feedback loop with NDRG1, promoting melanoma progression and metastasis.

bioRxiv · Feb 27, 2023 · PreprintCancer Biology

Inhibiting mitochondrial translation overcomes multidrug resistance in MYC-driven neuroblastoma via OMA1-mediated integrated stress response

K. Borankova, M. Krchniakova, L. Y. Leck, J. Neradil, A. Kubistova, P. J. Jansson, M. D. Hogarty, J. Skoda

bioRxiv · Feb 24, 2023Cancer Biology

REDUCED ER-MITOCHONDRIA CONNECTIVITY PROMOTES NEUROBLASTOMA MULTIDRUG RESISTANCE

J. Coku, D. M. Booth, J. Skoda, M. C. Pedrotty, J. Vogel, K. Liu, A. Vu, E. L. Carpenter, J. C. Ye, M. A. Chen, P. Dunbar, E. Scadden, E. Nakamaru-Ogiso, Y. Li, K. C. Goldsmith, , M. D. Hogarty

The paper identifies reduced ER-mitochondria contacts as a mechanism promoting neuroblastoma multidrug resistance by impairing Ca2+ transfer and apoptosis.

bioRxiv · Mar 1, 2021Cancer Biology